Hain Celestial expected to report $430.5 million revenue, down 5.2% with $0.12 EPS
From Stockstory.org – CNBC: 2025-02-09 08:02:37 Hain Celestial (NASDAQ:HAIN) is set to report earnings tomorrow. Last quarter, the company met
From Stockstory.org – CNBC: 2025-02-09 08:02:37 Hain Celestial (NASDAQ:HAIN) is set to report earnings tomorrow. Last quarter, the company met
From Stock Story: 2025-02-09 08:02:10 Biopharmaceutical company Incyte Corporation (NASDAQ:INCY) is set to report earnings tomorrow, with analysts expecting revenue
From Stock Story.: 2025-02-09 08:01:58 Rockwell Automation (NYSE:ROK) is set to report earnings, with analysts expecting a 7.8% revenue decline
From StockStory: 2025-02-09 08:01:56 Fluence Energy is set to report earnings tomorrow after market hours. Last quarter, the company missed
From Barchart: 2025-02-09 08:00:02 Nvidia reported a record-breaking revenue of $6.51 billion in the third quarter, exceeding expectations by 8%.
From Nasdaq: 2025-02-09 07:30:00 Palantir Technologies’ (NASDAQ: PLTR) stock price soared past $100 after strong Q4 earnings highlighted its momentum
From Nasdaq: 2025-02-09 06:37:00 Investing in individual stocks can be risky, with 40% of stocks in the Russell 3000 index
From Nasdaq: 2025-02-09 05:30:00 XRP and Bitcoin are both strong cryptocurrencies, but they differ in value and performance. XRP is
From Nasdaq: 2025-02-09 05:06:00 Investors looking for growth stocks can turn to the Nasdaq exchange, with the exclusive Nasdaq-100 index
From Nasdaq: 2025-02-09 04:05:00 Bitcoin has seen a massive 956% increase in the past five years, outperforming major stock indexes.
From Investing.com: 2025-02-09 02:28:00 The main macro thesis for the first half of 2025 predicts another disinflationary wave hitting the
From Nasdaq: 2025-02-08 23:59:20 4D Molecular Therapeutics (FDMT) shared positive interim data from the Phase 2b PRISM trial, showcasing the
From Nasdaq: 2025-02-08 23:36:47 Regeneron Pharmaceuticals Inc. announced positive results from the Phase 3 QUASAR trial, testing EYLEA HD for
From NASDAQ.: 2025-02-08 23:17:46 Regeneron Pharmaceuticals announced positive three-year results for EYLEA HD in patients with wet age-related macular degeneration.
From Nasdaq: 2025-02-08 18:50:00 Enterprise Products Partners (NYSE: EPD) reported strong fourth-quarter earnings, with total gross operating profit up 3%
From Nasdaq: 2025-02-08 18:41:00 Adyen’s stock saw a 50% drop from its highs due to the pandemic tailwind turning into
From Nasdaq: 2025-02-08 18:32:00 Research analysts play a crucial role in shaping investor perceptions of businesses. One top stock has
From Nasdaq: 2025-02-08 18:23:00 McDonald’s (NYSE: MCD) is a dominant force in the fast-food industry, boasting the largest number of
From Nasdaq: 2025-02-08 18:14:00 Nike stock (NYSE: NKE) soared by 255% in the five years leading up to November 2021
From Nasdaq: 2025-02-08 18:05:00 The stock of United Parcel Service (UPS) has dropped 17.5% since reporting Q4 and full-year 2024
From Nasdaq: 2025-02-08 18:00:00 Estimating your retirement needs can be complex, with the common suggestion to save 10% of your
From Nasdaq: 2025-02-08 16:00:00 Many Americans choose to claim Social Security retirement benefits while still working to enjoy a higher
From Nasdaq, Inc.: 2025-02-08 15:00:00 Validea’s guru fundamental report for Morningstar Inc. (MORN) shows that it rates highest using the
From Nasdaq: 2025-02-08 15:00:00 Validea’s guru fundamental report for AMC ENTERTAINMENT HOLDINGS INC (AMC) shows it rates highest using the
From GlobeNewswire: 2025-02-08 14:30:24 4D Molecular Therapeutics announced positive interim 52-week data for 4D-150 in wet age-related macular degeneration (wet